Showing results (1881-1890 of 2,243) with videos related to

Sort By:
Pageof 225
Plos One|January 14, 2012
Inflammatory-induced hibernation in the fetus: priming of fetal sheep metabolism correlates with developmental brain injuryMatthias Keller, David P Enot, Mark P Hodson, et al.
The Annals of Thoracic Surgery|March 6, 2012
Hypothermia severely effects performance of nitinol-based endovascular grafts in vitroMichael P Robich, Robert Hagberg, Marc L Schermerhorn, et al.
BJUI Compass|May 7, 2025
Risk of upper urinary tract urothelial carcinoma after primary non-muscle-invasive urinary bladder cancer: A nationwide population-based cohort studyChristel Häggström, Oskar Hagberg, Lars Holmberg, et al.
Pediatric Research|May 31, 2024
Novel biomarkers of preterm brain injury from blood transcriptome in sheep model of intrauterine asphyxiaC Joakim Ek, Mårten Alkmark, Ana A Baburamani, et al.
Frontiers in Psychiatry|May 9, 2022
Mechanical Affective Touch Therapy for Anxiety Disorders: Feasibility, Clinical Outcomes, and Electroencephalography Biomarkers From an Open-Label TrialLinda L Carpenter, Eugenia F Kronenberg, Eric Tirrell, et al.
International Journal of Rehabilitation Research. Internationale Zeitschrift Fur Rehabilitationsforschung. Revue Internationale De Recherches De Readaptation|November 25, 2003
Early community outreach intervention in children with acquired brain injuryI Emanuelson, L V Wendt, I Hagberg, et al.
Neuropediatrics|December 1, 1996
Disorders of the cerebral white matter in children. The spectrum of lesionsR Kristjánsdóttir, P Uvebrant, B Hagberg, et al.
Pediatric Research|November 12, 2019
Microbial invasion of the amniotic cavity is associated with impaired cognitive and motor function at school age in preterm childrenAnna Thorell, Maria Hallingström, Henrik Hagberg, et al.
Arthritis Research & Therapy|October 26, 2018
Cytokine production by activated plasmacytoid dendritic cells and natural killer cells is suppressed by an IRAK4 inhibitorKarin Hjorton, Niklas Hagberg, Elisabeth Israelsson, et al.
Leukemia & Lymphoma|January 19, 2008
Long-term molecular remissions in patients with indolent lymphoma treated with rituximab as a single agent or in combination with interferon alpha-2a: a randomized phase II study from the Nordic Lymphoma GroupEva Kimby, Jesper Jurlander, Christian Geisler, et al.
Pageof 225